World's Best Scientists 2026 revealed!
Donna Niedzwiecki

Donna Niedzwiecki

D-Index & Metrics

Medicine

D-Index
95
Citations
35653
World Ranking
10006
National Ranking
5150

Donna Niedzwiecki publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Donna Niedzwiecki sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 486 publications — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Donna Niedzwiecki D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Donna Niedzwiecki sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 95 D-Index — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Donna Niedzwiecki is affiliated with Duke University in the United States and has a research focus primarily within the field of Medicine, with a strong emphasis on Oncology.

Their work spans several subfields of study that include Oncology, Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine, and Radiology, Nuclear Medicine and Imaging.

The main topics explored in their research encompass:

  • Colorectal Cancer Treatments and Studies
  • Gastric Cancer Management and Outcomes
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Screening and Detection
  • Brain Metastases and Treatment
  • Advanced Radiotherapy Techniques
  • Esophageal Cancer Research and Treatment

Donna Niedzwiecki's recent notable publications include:

  • Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials, 2020, The Lancet Oncology
  • Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial, 2021, Journal of Clinical Oncology
  • Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer, 2021, JAMA
  • Racial and Socioeconomic Disparities in Utilization of Telehealth in Patients with Liver Disease During COVID-19, 2021, Digestive Diseases and Sciences
  • Assessment of Capecitabine and Bevacizumab With or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer, 2022, JAMA Network Open

The scientist frequently publishes in several journals including:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology•Biology•Physics
  • The American Journal of Gastroenterology
  • UNC Libraries
  • Gastroenterology

Frequent collaborators in their research endeavors include:

  • Alice Parish
  • Richard M. Goldberg
  • Alan P. Venook
  • Robert J. Mayer
  • Jeffrey A. Meyerhardt

Best Publications

  • Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

    Joel Tepper;Mark J. Krasna;Donna Niedzwiecki;Donna Hollis

  • Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

    Hedy Lee Kindler;Donna Niedzwiecki;Donna Hollis;Susan Sutherland

  • Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

    Jeffrey A. Meyerhardt;Denise Heseltine;Donna Niedzwiecki;Donna Hollis

  • Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

    Axel Grothey;Alberto F. Sobrero;Anthony F. Shields;Takayuki Yoshino

  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

    Alan P. Venook;Donna Niedzwiecki;Heinz Josef Lenz;Federico Innocenti

  • Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials

    Edward L. Korn;Ping Yu Liu;Sandra J. Lee;Judith Anne W. Chapman

  • Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison

    DC Rockey;E Paulson;D Niedzwiecki;W Davis

  • Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

    Axel Heiser;Doris Coleman;Jens Dannull;Donna Yancey

  • Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer

    Joel E. Tepper;Michael J. O’Connell;Donna Niedzwiecki;Donna Hollis

  • Immunological and Clinical Responses in Metastatic Renal Cancer Patients Vaccinated with Tumor RNA-transfected Dendritic Cells

    Zhen Su;Jens Dannull;Axel Heiser;Donna Yancey

  • Irinotecan Fluorouracil Plus Leucovorin Is Not Superior to Fluorouracil Plus Leucovorin Alone As Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803

    Leonard B. Saltz;Donna Niedzwiecki;Donna Hollis;Richard M. Goldberg

  • Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer

    Jeffrey A. Meyerhardt;Donna Niedzwiecki;Donna Hollis;Leonard B. Saltz

  • CALGB/SWOG 80405: Phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC).

    Alan P. Venook;Donna Niedzwiecki;Heinz-Josef Lenz;Federico Innocenti

  • Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B Protocol 89803.

    Monica M. Bertagnolli;Donna Niedzwiecki;Carolyn C. Compton;Hejin P. Hahn

  • Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer.

    Zhen Su;Jens Dannull;Benjamin K. Yang;Philipp Dahm

  • Hepatic Arterial Infusion Versus Systemic Therapy for Hepatic Metastases From Colorectal Cancer: A Randomized Trial of Efficacy, Quality of Life, and Molecular Markers (CALGB 9481)

    Nancy E. Kemeny;Donna Niedzwiecki;Donna R. Hollis;Heinz-Josef Lenz

  • Frequent Inactivation of PTEN by Promoter Hypermethylation in Microsatellite Instability-High Sporadic Colorectal Cancers

    Ajay Goel;Christian N. Arnold;Christian N. Arnold;Donna Niedzwiecki;John M. Carethers;John M. Carethers

  • Adjuvant therapy in rectal cancer: Analysis of stage, sex, and local control - Final report of Intergroup 0114

    J. E. Tepper;M. O'Connell;D. Niedzwiecki;D. R. Hollis

  • FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.

    D Kelsen;O T Atiq;L Saltz;D Niedzwiecki

  • Impact of primary (1{o}) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): Analysis of CALGB/SWOG 80405 (Alliance).

    Alan P. Venook;Donna Niedzwiecki;Federico Innocenti;Briant Fruth

Frequent Co-Authors

Robert J. Mayer
Robert J. Mayer Dana-Farber Cancer Institute
Alan P. Venook
Alan P. Venook University of California, San Francisco
Jeffrey A. Meyerhardt
Jeffrey A. Meyerhardt Harvard University
Monica M. Bertagnolli
Monica M. Bertagnolli Brigham and Women's Hospital
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Federico Innocenti
Federico Innocenti University of North Carolina at Chapel Hill
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California
Charles D. Blanke
Charles D. Blanke Oregon Health & Science University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t end with becoming a physician. There are several related online degrees and career pathways that can complement or expand your role in healthcare. For instance, aspiring nurses can consider cheap dnp online programs to earn a Doctor of Nursing Practice degree affordably while maintaining their professional commitments.

Pharmacists can also advance their qualifications through an online pharmacist degree, making it easier to gain specialized expertise without relocating or disrupting their work schedules.

For those interested in healthcare management and technology, a bachelor of health information management online provides the skills needed for overseeing patient records and health data systems, a rapidly growing field in modern medicine.

In addition, roles in healthcare administration can begin with online certificates. Entry-level opportunities, such as medical billing and coding online courses, offer a faster way to join the healthcare workforce.

These diverse online pathways offer flexibility, cost-effectiveness, and a range of professional opportunities within the dynamic landscape of American healthcare.

Best Scientists Citing Donna Niedzwiecki

Trending Scientists

Recently Published Articles